GASTRIC NEUROENDOCRINE TUMOR G1

Clinical trials for GASTRIC NEUROENDOCRINE TUMOR G1 explained in plain language.

Never miss a new study

Get alerted when new GASTRIC NEUROENDOCRINE TUMOR G1 trials appear

Sign up with your email to follow new studies for GASTRIC NEUROENDOCRINE TUMOR G1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Major cancer trial tests new drug duos for rare, aggressive tumors

Disease control Ongoing

This large Phase 3 trial aims to find the better treatment combination for patients with advanced, high-risk neuroendocrine tumors (like carcinoid tumors) that have spread. Researchers are comparing a standard drug (octreotide) paired with either interferon or bevacizumab to see …

Matched conditions: GASTRIC NEUROENDOCRINE TUMOR G1

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

GASTRIC NEUROENDOCRINE TUMOR G1

Get alerted when new GASTRIC NEUROENDOCRINE TUMOR G1 trials appear

Major cancer trial tests new drug duos for rare, aggressive tumors